Latest filing published 20 Aug 2026 for CORCEPT THERAPEUTICS INC, €505k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David l. Mahoney is a declared insider at 2 companies; the most frequent names are Corcept Therapeutics Inc and Adamas Pharmaceuticals Inc. Between 11 May 2021 and 18 August 2026, the trades on record add up to 16 filings.
On the market, this insider has only sold: 6 sales, €10.9M in total. The totals do not cover 1 filing with an undisclosed amount. Besides market trades, the filings include 1 share grant and 7 option exercises. Since January 2026: no purchases and 5 sales on the market.
On 20 August 2026 came the latest disclosure, an open-market sale for €505k in Corcept Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations